¡Activa las notificaciones laborales por email!
Mejora tus posibilidades de llegar a la entrevista
Elabora un currículum adaptado a la vacante para tener más posibilidades de triunfar.
An established industry player is seeking a Regional Head for Business Planning and Analysis in the Real Estate and Facility Services sector. This pivotal role involves providing financial expertise and driving the achievement of financial targets across regions. You will partner with global finance teams, ensure cost transparency, and lead high-impact projects while managing a high-performing team. This role offers a unique opportunity to influence strategic decisions and make a significant impact on the organization’s success. If you have a strong financial background and a passion for leadership, this is the perfect opportunity for you.
Regional Head Business Planning & Analysis REFS (Real Estate and Facility Services) page is loaded
Band
Level 6Job Description Summary
Join Novartis as the Head Business Planning and Analysis REFS Rest of World region, which is a pivotal role that provides financial expertise and drives the achievement of REFS financial, transformation, and savings targets. As a key member of the REFS ROW LT and REFS Finance LT, this role acts as the strategic Finance partner for the REFS RoW Head.Job Description
Major accountabilities:
Minimum Requirements:
We are committed to building an outstanding, inclusive work environment and diverse teams representative of the patients and communities we serve.
Skills Desired
Ability To Influence Key Stakeholders, AI Driven, Building Effective Teams, Capital Allocation, Critical Thinking, Data Cleansing / Normalization, Data Visualization, Effective Communications, Embracing Change, Employee Engagement, Financial And Management, Insight Generation, Managing Ambiguity, Market Understanding, Planning & Analysis, Process Optimization, Rapid Problem Solving, Reporting, Understanding Value DriversOur purpose here at Sandoz is pioneering access for patients. Our broad global portfolio comprises about 1,500 quality biosimilar and generic medicines. We provide more than 800 million patient treatments per year, generating more than USD 18 billion in direct savings in the US and Europe alone, improving healthcare by freeing up resources and resulting in a total social impact estimated at around USD 400 billion per year worldwide.
At Sandoz, we're the leading global provider of ‘off-patent’ medicines. That means when product patents expire, we swiftly develop matching high-quality medicines, which are more affordable and accessible.
By making our off-patent medicines affordable and not just for the few, we’re freeing up resources, so healthcare systems can do more, with less.